That makes you a rookie investor in love with your stock, watch that share price drop to $100 and your love affair might come to an end. There are 50 other promising biotech stocks out there with great pipelines also.
If rumor is true, this stock easy over $200, if false.... who knows. The share price could fall $125 to $60. It appears to be a promising pipeline, but years away from market.
Evidence is history based, due to the fact that the SEC requires M & A offers to be made public when an offer includes a premium. Do your DD folks.
I think this company is very legitimate, and I don't doubt that some other biotech companies would be interested in merging. That said, there is NO evidence of any offers.... by anyone .... PERIOD !
I'm pretty sure this will not end well for some stock buyers.
It's not the job of the company to fend off false rumors of this type. However, if the offers were true, it would be in the best interest of the shareholders if the so called offers were made public.
Really, three companies made legitimate offers for the company and not one report from RCPT or the suitors ?
Come on folks.
I'm trading this stock, just because it's easy to jump in and out and make some coin.
However, as to the Takeout rumors, I have serious doubts. Googling time after time, the only reference I can find is and activist shareholder is the one making the claims, that is quite self serving as we have seen from other activist shareholders of other companies. Any serious offer from any other company needs to be made public. That is material information, and shareholders have a right to know, especially offers of the magnitude this activist shareholder is claiming. If somebody can point to something more concrete, I'm all ears.
In fact, I would contend that an activist investor with that kind of information better be careful about his/her trading or it it would could well be viewed as insider information since Receptos never made those offers public information.
I have serious doubts about these rumors, but I'll trade interday again tomorrow.
My understanding that PSEC leveraged to higher interest rates, this issue should be going up if that the case....anybody ?
This issue acting very weak, however, I see nothing wrong with KMI. If you listen to the Cramer interview. He basically flipped from KMI to ETP on the basis of a fatter dividend yield.
Looks like KMI will probably touch the 200 day average soon... currently around $40, hopefully a bounce at the 200 day average.
Mr. Cramer is no idiot as some would imply. That said, I learned long ago not to pay much attention to his stock picks. He flip flops too much, and plays pump and dump. His general investment advice is however quite sound.
I've also learned to try to follow the big money on Wall St.
A couple months back, some large amount of KMI Jan. 2017 $50 call options were purchased for about $1.35, the same expiration $60 strike was sold to help finance the purchased call options. So for about a net $1.00 per share, the Jan. 2017 $50 calls were purchased. Currently the open interest is almost 400.000 call options at the $50 strike, representing 40 millions shares... and $40M dollars.
Stay with the big money.
BTW- I purchased the same Jan. 2017 $50 calls for about $1.28 per share. So far I've financed them by selling the same expiration $30 puts for about $1.10 each. When the KMI share price moves higher, I will sell the $60 calls against my $50 calls, as big money already modeled.
Check out the open interest for yourself.
Trades more like a Utility.
Looks like it's trading on TA more than anything, test of support at or near $42, where it broke out weeks ago.
I doubt it drops much below $42... if at all.
Not sure but it looks like they actually beat the earnings estimate.
Thirty days ago, the estimate to loose .03 per share.
As off yesterday... $ 0.00 was the estimate since oil prices rebounded a tad.
Where the share price goes short term will be more about forward guidance than anything
He distorted many facts, I'd be surprised if they didn't buy the shares up to the point of the presentation and then start selling and sell short.
He said for example that drilling a hold is a 50 year investment... not the case for fracking.
Correct, I won't buy the likes of ICPT, these developmental biotech stocks are lunacy, not investing but gambling. Take it from me, I lost many many thousands on such biotech hopes. GW Pharma at least is the only legitimate company in the space, I'll give them that.
Fortunately I made back years of such biotech losses by investing in real companies like GILD AMGN CELG BIIB
If you wanna gamble.... have fun.
I'm not a hater... nor a shareholder.
Why the haters ?
Probably because the company is estimated to loose $3.14 per share this year, $4.14 per share for 2016. No estimated beyond that. But that carries enough risk to say that at $110, this issue is likely overvalued. It will be volatile for months to come.
Hold at your own risk.